FDA
Articles tagged with “FDA”
Ketamine Compounding Regulations in 2026: What Has Changed
An overview of the latest regulatory developments affecting compounded ketamine in 2026, including FDA enforcement updates, state-level changes, and the impact on patient access.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Intranasal Ketamine and Esketamine (Spravato)
A comprehensive guide to intranasal ketamine therapy, including the FDA-approved esketamine nasal spray Spravato — how it works, the REMS program, and clinical considerations.
A Complete History of Ketamine: From Anesthetic to Antidepressant
A comprehensive timeline of ketamine's history spanning over six decades — from its 1962 synthesis to its modern role as a groundbreaking psychiatric treatment.
History of Ketamine
A timeline of ketamine's journey from its synthesis in 1962 as a surgical anesthetic to its modern role as a groundbreaking psychiatric treatment.
Esketamine: The S-Enantiomer Behind Spravato
A glossary entry on esketamine, the S-enantiomer of ketamine marketed as Spravato, covering its pharmacology, FDA approval, and clinical significance.
Is Ketamine Legal for Therapy?
A clear explanation of ketamine's legal status in the United States and internationally, including FDA-approved uses, off-label prescribing, and controlled substance classification.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.